Company news

EyePoint, Inc. news in 2019

EyePoint, Inc.'s news releases, calls and decks from 2019, newest first.

View company

EyePoint Pharmaceuticals Announces New Agreement for Expanded Access of DEXYCU® Within One of the Largest Integrated Delivery Systems in the U.S.

December 3, 2019

EyePoint Pharmaceuticals Announces Amendment to CRG Debt Facility

November 18, 2019

EyePoint Pharmaceuticals Appoints George O. Elston as Chief Financial Officer and Head of Corporate Development

November 13, 2019

EyePoint Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Corporate Progress

November 6, 2019

EyePoint Pharmaceuticals Announces Addition of DEXYCU® and YUTIQ® to Department of Veteran Affairs Federal Supply Schedule

November 3, 2019

EyePoint Pharmaceuticals Secures New Patient Access Agreement with Vizient Inc. for DEXYCU®

October 31, 2019

EyePoint Pharmaceuticals Announces Third Quarter 2019 Financial Results Release Date and Conference Call Information

October 23, 2019

EyePoint Pharmaceuticals Announces Permanent and Specific J-Code for YUTIQ® Now in Effect

October 1, 2019

EyePoint Pharmaceuticals Announces YUTIQ® Presentations at the American Academy of Ophthalmology 2019 Annual Meeting

September 26, 2019

EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ® to be Presented at the 52nd Annual Retina Society Scientific Meeting

September 8, 2019

EyePoint Pharmaceuticals, Inc. - U.S. Commercialization of DEXYCU® (dexamethasone intraocular suspension) 9%

July 7, 2019

Decks in 2019